117th Congress · HOUSE BILLBILL

H.R. 6973 — Enhanced Access to Affordable Medicines Act of 2022

“To amend the Federal Food, Drug, and Cosmetic Act to clarify the conditions under which the Secretary of Health and Human Services can approve generic drug applications with labeling temporarily different than the brand name drug, and for other purposes.”

Health

Introduced Mar 8, 2022

Last action Mar 9, 2022

Pipeline · Bill → Law

Step 1

Introduced

Mar 8, 2022

Step 2

Referred

Mar 9, 2022

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Mar 9, 2022

Referred to the Subcommittee on Health.

Mar 8, 2022

Introduced in House

Mar 8, 2022

Referred to the House Committee on Energy and Commerce.